Covid19 Related Anosmia and Aguesia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Covid19 Related Anosmia and Aguesia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 3

NCT04830943

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

The loss of smell and taste is a prominent symptom of COVID-19. Studies found that patterns of smell loss due to Covid-19 infection differ from that of other re…

Egypt250 participantsStarted 2020-08-01

Treatment: Cerebrolysin